Medication program persistence and engagement: January 2026 analysis of 30,239 Noom GLP-1 Rx Program members who started a GLP-1 Rx plan between December 2024 and February 2025, evaluating program persistence by engagement quartile
ROS actively mediate cellular responses to a variety of stimuli directly or indirectly regulated by oxidative stress
In pooled clinical trial data, injection site reactions occurred in 4.6% of tirzepatide-treated patients who developed anti-tirzepatide antibodies, compared to only 0.7% of those who did not develop antibodies
But, it can cause certain symptoms to return as the drug leaves your system, such as nausea, constipation, or irritability
Thalassaemia gene therapy trial shows 'encouraging' results Scientists say they are "excited" by the results of a gene therapy trial for the inherited blood disorder beta-thalassaemia, which reduced the need for blood transfusions